Impact BioMedical Inc (AMEX:IBO) shares, rose in value on Friday, May 30, with the stock price up by 5.31% to the previous day’s close as strong demand from buyers drove the stock to $0.52.
Actively observing the price movement in the last trading, the stock closed the session at $0.49. Referring to stock’s 52-week performance, its high was $6.17, and the low was $0.37. On the whole, IBO has fluctuated by 20.84% over the past month.
With the market capitalization of Impact BioMedical Inc currently standing at about $6.24 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
The stock’s technical analysis shows that the price of IBO currently trading nearly -6.41% and -40.46% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.28, while the 7-day volatility ratio is showing 4.94% which for the 30-day chart, stands at 16.21%. Furthermore, Impact BioMedical Inc (IBO)’s average true range (ATR) is 0.10.
Data on historical trading for Impact BioMedical Inc (AMEX:IBO) indicates that the trading volumes over the past 3 months, they’ve averaged 9.54 million. According to company’s latest data on outstanding shares, there are 12.09 million shares outstanding.
Nearly 0.85% of Impact BioMedical Inc’s shares belong to company insiders and institutional investors own 3.19% of the company’s shares. The stock has fallen by -64.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IBO stock heading into the next quarter.
